Companies: 10,795·Total market cap: $144.5T

LadRx Corporation

LadRx Corporation

LADXOTCHealthcare● Active

$0.11

+$0.10(+872.73%)

Market Cap$52975

P/E Ratio—

52W High$2.4

52W Low$0.01

Avg Volume113

Open$0.11

Beta1.24

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

LadRx Corporation（LADX）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · LADX · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-5.04Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)6922.00Full revenue history

Dividend Yield16.07%Dividend history

Shares Outstanding495,092Shares outstanding history

Next EarningsTBAEarnings history

探索 LadRx Corporation 数据

分析师预测—

盈利EPS $-3210.89-472289.71%

财务快照

FY 2024Revenue$0.00

202220232024

FY 2024Net Income-$1.59B▼ 397081.59% YoY

202220232024

FY 2024EPS$-3210.89▼ 472289.71% YoY

202220232024

TTM:Revenue: $6922.00Net Income: -$2.5MEPS: $-5.04View income statement →

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

LadRx Corporation

$0.11+872.73%$52,975 #2

Acro Biomedical Co., Ltd.

$0.03+0.00%$1.6M #3

Biome Grow Inc.

$0.00+0.00%$56,208 #4

DNAPrint Genomics, Inc.

$0.00+0.00%$12,892 #5

Instadose Pharma Corp.

$0.00+0.00%$53,193 #6

$0.00+0.00%$2,702

股票表现

1D+872.73%

1W+0.00%

1M-2.73%

3M+970.00%

YTD+970.00%

1Y-93.78%

5Y-99.95%

关于 LadRx Corporation

CEOJohn Y. Caloz

IPO DateMar 29, 1989

Employees2

CountryUS

Websitecytrx.com

LadRx Corporation is a biopharmaceutical firm dedicated to researching and developing innovative treatments for cancer patients. Its flagship compound, aldoxorubicin, an advanced drug conjugate derive…

Biotechnology HealthcareOTCUS

关于股票概览与关键数据

LadRx Corporation（LADX）是 Biotechnology 行业的 Healthcare 类公司，于 Mar 29, 1989 在 OTC 上市。截至最近交易日，LADX 股价为 $0.11，市值约为 $52,975。过去12个月累计回报 -93.78%，年初至今回报 +970.00%。

2024 财年 LadRx Corporation 营收 —。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，LadRx Corporation（LADX）股价为 $0.11，在 OTC 上市，52周区间为 $0.01 – $2.40。

LADX 最新股价LADX quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议